MeSH term
Frequency | Condition_Probility | Animals | 34 | 0.0 |
Humans | 85 | 0.0 |
Adult | 19 | 0.0 |
Female | 59 | 0.0 |
In Situ Hybridization, Fluorescence | 10 | 0.0 |
Karyotyping | 24 | 1.0 |
Male | 67 | 0.0 |
Research Support, Non-U.S. Gov't | 52 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Adolescent | 11 | 0.0 |
DNA-Binding Proteins/*genetics | 28 | 1.0 |
Genotype | 4 | 0.0 |
Gonadal Dysgenesis, 46,XY/*genetics | 5 | 55.0 |
*Nuclear Proteins | 49 | 2.0 |
Polymerase Chain Reaction | 20 | 0.0 |
Sex Chromosome Aberrations | 2 | 8.0 |
*Transcription Factors | 35 | 2.0 |
Y Chromosome/*genetics | 7 | 9.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Mice | 17 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Phenotype | 10 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Sex Determination (Genetics) | 7 | 19.0 |
Y Chromosome | 13 | 15.0 |
Child | 9 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Y/*genetics | 2 | 11.0 |
Genes, sry/genetics | 2 | 33.0 |
Hermaphroditism/*genetics | 4 | 40.0 |
*Mosaicism | 3 | 5.0 |
*Sex Chromosome Aberrations | 3 | 10.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
High Mobility Group Proteins/*metabolism | 2 | 6.0 |
DNA/genetics | 2 | 0.0 |
Gonads/embryology | 2 | 25.0 |
Hermaphroditism/genetics/pathology | 2 | 100.0 |
High Mobility Group Proteins/genetics/physiology | 2 | 50.0 |
Mutation | 11 | 0.0 |
Sex Differentiation/genetics/physiology | 2 | 40.0 |
Transcription Factors/genetics/physiology | 3 | 4.0 |
*Genes, sry | 4 | 40.0 |
Amino Acid Sequence | 22 | 0.0 |
High Mobility Group Proteins/*genetics | 6 | 6.0 |
Molecular Sequence Data | 36 | 0.0 |
Phylogeny | 3 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Ovary/embryology | 2 | 15.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
*Sex Reversal, Gonadal | 11 | 25.0 |
Testis/embryology | 2 | 9.0 |
Transcription, Genetic | 6 | 0.0 |
X Chromosome | 7 | 1.0 |
Cell Line | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Nuclear Family | 2 | 0.0 |
Pregnancy | 5 | 0.0 |
Prenatal Diagnosis | 2 | 1.0 |
Sex Differentiation Disorders/*genetics | 5 | 41.0 |
X Chromosome/*genetics | 2 | 0.0 |
*Mutation | 3 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Fetus/physiology | 2 | 4.0 |
Transcription Factors/*genetics | 4 | 0.0 |
*Sex Determination (Genetics) | 10 | 18.0 |
*X Chromosome | 7 | 0.0 |
Base Sequence | 29 | 0.0 |
Blotting, Southern | 7 | 0.0 |
Chromosome Banding | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Sex Differentiation/*genetics | 5 | 18.0 |
DNA-Binding Proteins/genetics/physiology | 3 | 3.0 |
Receptors, Retinoic Acid/genetics/physiology | 2 | 18.0 |
*Repressor Proteins | 3 | 0.0 |
Sex Reversal, Gonadal | 2 | 8.0 |
X Chromosome/genetics | 2 | 1.0 |
Y Chromosome/genetics | 6 | 20.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Child, Preschool | 5 | 0.0 |
Comparative Study | 6 | 0.0 |
Infant | 5 | 0.0 |
Testis/*abnormalities | 3 | 60.0 |
Chromosome Deletion | 3 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Time Factors | 2 | 0.0 |
DNA/*analysis/genetics | 2 | 13.0 |
*Polymerase Chain Reaction | 2 | 0.0 |
Sex Determination (Analysis)/*methods | 6 | 60.0 |
Evolution, Molecular | 2 | 0.0 |
Mammals | 3 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Translocation, Genetic/*genetics | 3 | 1.0 |
*Y Chromosome | 13 | 10.0 |
Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Sex Differentiation/genetics | 2 | 11.0 |
Models, Molecular | 2 | 0.0 |
*Sex Characteristics | 2 | 1.0 |
Sex Chromosome Aberrations/*genetics | 4 | 6.0 |
Autoradiography | 2 | 0.0 |
Temperature | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Pedigree | 4 | 0.0 |
Abnormalities, Multiple/*genetics | 3 | 0.0 |
*Chromosomes, Human, Pair 4 | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
Mosaicism/*genetics | 2 | 5.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Mammals/*genetics | 4 | 11.0 |
Sex Determination (Analysis) | 3 | 10.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Binding Sites | 2 | 0.0 |
*Sex Determination (Analysis) | 8 | 25.0 |
English Abstract | 5 | 0.0 |
DNA/analysis | 4 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Gestational Age | 2 | 0.0 |
Testis/*embryology | 2 | 20.0 |
Genetic Markers | 2 | 0.0 |
Transcription Factors/genetics | 4 | 0.0 |
Zinc Fingers/genetics | 2 | 1.0 |
Open Reading Frames | 3 | 0.0 |
Pseudohermaphroditism/*genetics | 2 | 14.0 |
DNA | 2 | 0.0 |
Goats | 2 | 2.0 |
Gene Library | 2 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Genes, sry | 2 | 100.0 |
Syndrome | 4 | 0.0 |
DNA Methylation | 2 | 0.0 |
Chromosomes, Human, X | 2 | 6.0 |
